Schworer E, Altaye M, Fidler D, Beebe D, Wiley S, Hoffman E
Int J Environ Res Public Health. 2023; 20(6).
PMID: 36982110
PMC: 10049659.
DOI: 10.3390/ijerph20065202.
Iulita M, Garzon Chavez D, Christensen M, Tamayo N, Plana-Ripoll O, Rasmussen S
JAMA Netw Open. 2022; 5(5):e2212910.
PMID: 35604690
PMC: 9127560.
DOI: 10.1001/jamanetworkopen.2022.12910.
Hartley S, Handen B, Tudorascu D, Lee L, Cohen A, Piro-Gambetti B
Alzheimers Dement (Amst). 2022; 14(1):e12256.
PMID: 35386473
PMC: 8976157.
DOI: 10.1002/dad2.12256.
Silverman W, Krinsky-McHale S, Zigman W, Schupf N
Alzheimers Dement. 2021; 18(10):1736-1743.
PMID: 34873819
PMC: 10302784.
DOI: 10.1002/alz.12520.
Jojoa-Acosta M, Signo-Miguel S, Garcia-Zapirain M, Gimeno-Santos M, Mendez-Zorrilla A, Vaidya C
Int J Environ Res Public Health. 2021; 18(20).
PMID: 34682531
PMC: 8536074.
DOI: 10.3390/ijerph182010785.
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer's Disease.
Rujeedawa T, Carrillo Felez E, Clare I, Fortea J, Strydom A, Rebillat A
J Clin Med. 2021; 10(19).
PMID: 34640600
PMC: 8509365.
DOI: 10.3390/jcm10194582.
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease.
Aschenbrenner A, Baksh R, Benejam B, Beresford-Webb J, Coppus A, Fortea J
Alzheimers Dement (Amst). 2021; 13(1):e12184.
PMID: 33969175
PMC: 8088591.
DOI: 10.1002/dad2.12184.
Screening of Cognitive Changes in Adults with Intellectual Disabilities: A Systematic Review.
Paiva A, Nolan A, Thumser C, Santos F
Brain Sci. 2020; 10(11).
PMID: 33198271
PMC: 7698112.
DOI: 10.3390/brainsci10110848.
The AT(N) framework for Alzheimer's disease in adults with Down syndrome.
Rafii M, Ances B, Schupf N, Krinsky-McHale S, Mapstone M, Silverman W
Alzheimers Dement (Amst). 2020; 12(1):e12062.
PMID: 33134477
PMC: 7588820.
DOI: 10.1002/dad2.12062.
Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome.
Hartley S, Handen B, Devenny D, Tudorascu D, Piro-Gambetti B, Zammit M
Alzheimers Dement (Amst). 2020; 12(1):e12096.
PMID: 32995465
PMC: 7507534.
DOI: 10.1002/dad2.12096.
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology.
Handen B, Lott I, Christian B, Schupf N, OBryant S, Mapstone M
Alzheimers Dement (Amst). 2020; 12(1):e12065.
PMID: 32775597
PMC: 7396809.
DOI: 10.1002/dad2.12065.
Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome.
Cody K, Piro-Gambetti B, Zammit M, Christian B, Handen B, Klunk W
Neurobiol Aging. 2020; 93:44-51.
PMID: 32447011
PMC: 7380565.
DOI: 10.1016/j.neurobiolaging.2020.04.018.
Reduced Acoustic Startle Response and Prepulse Inhibition in the Tg4-42 Model of Alzheimer's Disease.
Sichler M, Low M, M Schleicher E, Bayer T, Bouter Y
J Alzheimers Dis Rep. 2019; 3(1):269-278.
PMID: 31867566
PMC: 6918877.
DOI: 10.3233/ADR-190132.
Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.
Startin C, Hamburg S, Hithersay R, Al-Janabi T, Mok K, Hardy J
Alzheimers Dement. 2018; 15(2):245-257.
PMID: 30503169
PMC: 6374283.
DOI: 10.1016/j.jalz.2018.08.009.
Aging With Down Syndrome: The Dual Diagnosis: Alzheimer's Disease and Down Syndrome.
Cipriani G, Danti S, Carlesi C, Fiorino M
Am J Alzheimers Dis Other Demen. 2018; 33(4):253-262.
PMID: 29504408
PMC: 10852513.
DOI: 10.1177/1533317518761093.
Outcome Measures for Clinical Trials in Down Syndrome.
Esbensen A, Hooper S, Fidler D, Hartley S, Edgin J, Liogier DArdhuy X
Am J Intellect Dev Disabil. 2017; 122(3):247-281.
PMID: 28452584
PMC: 5424621.
DOI: 10.1352/1944-7558-122.3.247.
The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.
Lautarescu B, Holland A, Zaman S
Neuropsychol Rev. 2017; 27(1):31-45.
PMID: 28289920
PMC: 5359367.
DOI: 10.1007/s11065-017-9341-9.
Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial.
Cooper S, Ademola T, Caslake M, Douglas E, Evans J, Greenlaw N
Trials. 2016; 17:370.
PMID: 27473843
PMC: 4966871.
DOI: 10.1186/s13063-016-1370-9.
Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB).
Sinai A, Hassiotis A, Rantell K, Strydom A
PLoS One. 2016; 11(5):e0153917.
PMID: 27171413
PMC: 4865091.
DOI: 10.1371/journal.pone.0153917.
Alzheimer's Model Develops Early ADHD Syndrome.
Zhang Q, Du G, John V, Kapahi P, Bredesen D
J Neurol Neurophysiol. 2016; 6(6):1-6.
PMID: 26753104
PMC: 4704098.